Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting

---
identifier: "/us/fr/2010-13484"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2010-13484"
section_name: "Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting"
positive_law: false
currency: "2010-06-04"
last_updated: "2010-06-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
document_number: "2010-13484"
document_type: "notice"
publication_date: "2010-06-04"
agencies:
  - "DEPARTMENT OF HEALTH AND HUMAN SERVICES"
  - "National Institutes of Health"
---


#  Office of Biotechnology Activities; Recombinant DNA Research: Amended Notice of Meeting

**ACTION:**

Notice of cancellation of consideration of a proposed action  under Section III-A-1 of the *NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).*

**SUMMARY:**

Notice of a discussion of a proposed action under Section III-A-1 published on May 24, 2010 (75 FR 28811) is withdrawn. The discussion that was to be held at the June 16-17, 2010 meeting of the NIH Recombinant DNA Advisory Committee has been deferred at the request of the principal investigator.

**FOR FURTHER INFORMATION CONTACT:**

OBA by e-mail at *[email protected],* or telephone at 301-496-9838, if you have questions, or require additional information.

Dated: May 26, 2010.

Jacqueline Corrigan-Curay,

Acting Director, Office of Biotechnology Activities, National Institutes of Health.